PMC:7195088 / 18680-18881 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"664","span":{"begin":73,"end":81},"obj":"Species"},{"id":"767","span":{"begin":14,"end":24},"obj":"Chemical"},{"id":"768","span":{"begin":35,"end":45},"obj":"Chemical"},{"id":"769","span":{"begin":51,"end":61},"obj":"Chemical"},{"id":"925","span":{"begin":97,"end":115},"obj":"Disease"}],"attributes":[{"id":"A664","pred":"tao:has_database_id","subj":"664","obj":"Tax:9606"},{"id":"A767","pred":"tao:has_database_id","subj":"767","obj":"MESH:D007978"},{"id":"A768","pred":"tao:has_database_id","subj":"768","obj":"MESH:D019819"},{"id":"A769","pred":"tao:has_database_id","subj":"769","obj":"MESH:D000068759"},{"id":"A925","pred":"tao:has_database_id","subj":"925","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"oroquine plus levamisole pill plus budesonide plus formoterol inhaler in patients with nonsevere COVID-19 pneumonia. Partly blinded RCT (NCT04331470, not yet recruiting). Primary endpoint: (a) clear CT"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T23","span":{"begin":106,"end":115},"obj":"Phenotype"}],"attributes":[{"id":"A23","pred":"hp_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"oroquine plus levamisole pill plus budesonide plus formoterol inhaler in patients with nonsevere COVID-19 pneumonia. Partly blinded RCT (NCT04331470, not yet recruiting). Primary endpoint: (a) clear CT"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T91","span":{"begin":97,"end":105},"obj":"Disease"},{"id":"T92","span":{"begin":106,"end":115},"obj":"Disease"}],"attributes":[{"id":"A91","pred":"mondo_id","subj":"T91","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A92","pred":"mondo_id","subj":"T92","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"}],"text":"oroquine plus levamisole pill plus budesonide plus formoterol inhaler in patients with nonsevere COVID-19 pneumonia. Partly blinded RCT (NCT04331470, not yet recruiting). Primary endpoint: (a) clear CT"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T95","span":{"begin":190,"end":191},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"oroquine plus levamisole pill plus budesonide plus formoterol inhaler in patients with nonsevere COVID-19 pneumonia. Partly blinded RCT (NCT04331470, not yet recruiting). Primary endpoint: (a) clear CT"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T169","span":{"begin":14,"end":24},"obj":"Chemical"},{"id":"T170","span":{"begin":35,"end":45},"obj":"Chemical"},{"id":"T171","span":{"begin":51,"end":61},"obj":"Chemical"}],"attributes":[{"id":"A169","pred":"chebi_id","subj":"T169","obj":"http://purl.obolibrary.org/obo/CHEBI_6432"},{"id":"A170","pred":"chebi_id","subj":"T170","obj":"http://purl.obolibrary.org/obo/CHEBI_3207"},{"id":"A171","pred":"chebi_id","subj":"T171","obj":"http://purl.obolibrary.org/obo/CHEBI_5147"}],"text":"oroquine plus levamisole pill plus budesonide plus formoterol inhaler in patients with nonsevere COVID-19 pneumonia. Partly blinded RCT (NCT04331470, not yet recruiting). Primary endpoint: (a) clear CT"}

{"project":"LitCovid-sentences","denotations":[{"id":"T127","span":{"begin":117,"end":170},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"oroquine plus levamisole pill plus budesonide plus formoterol inhaler in patients with nonsevere COVID-19 pneumonia. Partly blinded RCT (NCT04331470, not yet recruiting). Primary endpoint: (a) clear CT"}